Clinicopathological characteristics and prognostic factors of patients with siewert type II esophagogastric junction carcinoma: a retrospective multicenter study
T Matsuda, Y Kurokawa, T Yoshikawa… - World Journal of …, 2016 - Wiley Online Library
Background The incidence of esophagogastric junction (EGJ) carcinoma is increasing, but
its optimal surgical management remains controversial. Methods We retrospectively …
its optimal surgical management remains controversial. Methods We retrospectively …
Solitary lymph node recurrence of esophageal squamous cell carcinoma: surgical failure or systemic disease?
T Makino, M Yamasaki, H Miyata, K Tanaka… - Annals of surgical …, 2016 - Springer
Background Post-surgical solitary lymph node recurrence (SLNR) may be a characteristic of
esophageal squamous cell carcinoma (ESCC). Methods Among 402 patients who …
esophageal squamous cell carcinoma (ESCC). Methods Among 402 patients who …
TNFAIP8 overexpression: a potential predictor of lymphatic metastatic recurrence in pN0 esophageal squamous cell carcinoma after Ivor Lewis esophagectomy
Z Sun, X Liu, JH Song, Y Cheng, Y Liu, Y Jia… - Tumor Biology, 2016 - Springer
Esophageal squamous cell carcinoma (ESCC) has a poor prognosis due to high lymphatic
metastatic recurrence rates after Ivor Lewis esophagectomy. We sought to investigate the …
metastatic recurrence rates after Ivor Lewis esophagectomy. We sought to investigate the …
High expression of cyclooxygenase 2 is an indicator of prognosis for patients with esophageal squamous cell carcinoma after I vor L ewis esophagectomy
D Hu, M Zhang, S Wang, Z Wang - Thoracic cancer, 2016 - Wiley Online Library
Background The poor prognosis of esophageal squamous cell carcinoma (ESCC) is
attributed to a high recurrence rate after surgery. Cyclooxygenase 2 (COX 2) is an important …
attributed to a high recurrence rate after surgery. Cyclooxygenase 2 (COX 2) is an important …
Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study
SY Moorcraft, E Fontana, D Cunningham, C Peckitt… - BMC cancer, 2016 - Springer
Background Oesophagogastric adenocarcinoma (OGA) has a poor prognosis, even for
patients with operable disease. However, the optimal surveillance strategy following surgery …
patients with operable disease. However, the optimal surveillance strategy following surgery …
Late recurrence after radical resection of esophageal cancer
Y Hiyoshi, N Yoshida, M Watanabe… - World journal of …, 2016 - Wiley Online Library
Abstract Background Approximately 10–20% of esophageal cancer patients in whom
recurrence is diagnosed experience late recurrence beyond 2 years after esophagectomy …
recurrence is diagnosed experience late recurrence beyond 2 years after esophagectomy …
Radiation field size and dose determine oncologic outcome in esophageal cancer
C Gemici, G Yaprak, HF Batirel, M Ilhan… - World journal of surgical …, 2016 - Springer
Background Locoregional recurrence is a major problem in esophageal cancer patients
treated with definitive concomitant chemoradiotherapy. Approximately half of the patients fail …
treated with definitive concomitant chemoradiotherapy. Approximately half of the patients fail …
Recurrence after surgery in esophago-gastric junction adenocarcinoma: current management and future perspectives
Recurrent esophago-gastric junction adenocarcinoma is not a rare event and its correct
management is still debated. Many approaches for the treatment of these patients exist, but …
management is still debated. Many approaches for the treatment of these patients exist, but …
[PDF][PDF] 食管源性转移瘤(癌) 的现状回顾与归纳
李国仁, 戴建华 - 中华胸部外科电子杂志, 2016 - cdn.amegroups.cn
食管源性转移瘤(癌) 是指食管原发性恶性肿瘤经血道转移到人体各部位的组织或器官.
发生移位状态的转移瘤(癌) 是临床治疗的难题和预后不良的主要原因, 也是目前肿瘤研究中的 …
发生移位状态的转移瘤(癌) 是临床治疗的难题和预后不良的主要原因, 也是目前肿瘤研究中的 …
Postoperative radiation therapy of pT2-3N0M0 esophageal carcinoma–a review
Y Luo, X Wang, J Yu, B Zhang, M Li - Tumor Biology, 2016 - Springer
Esophageal cancer is one of the most malignant gastrointestinal cancers worldwide. Despite
advances in surgical technique, 5-year survival in pathologic stage T2-3N0M0 esophageal …
advances in surgical technique, 5-year survival in pathologic stage T2-3N0M0 esophageal …